Merck shells out $10 billion for London-based Verona
Merck will buy UK-based Verona Pharma for about $10 billion, the companies said today, strengthening the US drugmaker's respiratory treatments as part of efforts to reduce dependence on its blockbuster cancer treatment.
Business
• 09 Jul
